5
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Oral manifestations of COVID‐19 and its management in pediatric patients: A systematic review and practical guideline

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus causes coronavirus disease 2019 (COVID‐19), a respiratory infection that has spread worldwide and is responsible for a high death toll. Although respiratory symptoms are the most common, there is growing evidence that oral signs of COVID‐19 can also be seen in children. The purpose of this systematic review is to provide a comprehensive analysis of the available data on the oral manifestations of COVID‐19 in children and to recommend appropriate methods of diagnosis and treatment.

          Methods

          A systematic search of the MEDLINE, EMBASE, Scopus, and Web of Science databases was done to discover relevant papers published between their establishment and January 2023. Articles detailing oral symptoms in pediatric patients with confirmed COVID‐19 infection were included, and data on clinical characteristics, diagnosis, treatment, and outcomes were extracted and evaluated.

          Results

          A total of 24 studies involving 2112 pediatric patients with COVID‐19 were included in the review. The most common presentations are oral lesions, taste and smell disorders, oral candidiasis, hemorrhagic crust, tongue discoloration, lip and tongue fissuring, gingivitis, and salivary gland inflammation. These manifestations were sometimes associated with multi‐system inflammatory syndrome in children (MIS‐C) or Kawasaki disease (KD). Management strategies varied depending on the severity of the oral manifestation and ranged from symptomatic relief with topical analgesics to systemic medications.

          Conclusion

          Oral symptoms of COVID‐19 are relatively prevalent in juvenile patients and can be accompanied by severe systemic diseases, such as MIS‐C or Kawasaki illness. Early detection and adequate care of these oral symptoms are critical for the best patient results. Understanding the underlying pathophysiology and developing targeted treatments requires more investigation.

          Related collections

          Most cited references63

          • Record: found
          • Abstract: found
          • Article: not found

          Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China

          To identify the epidemiological characteristics and transmission patterns of pediatric patients with the 2019 novel coronavirus disease (COVID-19) in China.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

            Abstract Background Understanding the epidemiology and clinical course of multisystem inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus disease 2019 (Covid-19) is important, given the clinical and public health implications of the syndrome. Methods We conducted targeted surveillance for MIS-C from March 15 to May 20, 2020, in pediatric health centers across the United States. The case definition included six criteria: serious illness leading to hospitalization, an age of less than 21 years, fever that lasted for at least 24 hours, laboratory evidence of inflammation, multisystem organ involvement, and evidence of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on reverse-transcriptase polymerase chain reaction (RT-PCR), antibody testing, or exposure to persons with Covid-19 in the past month. Clinicians abstracted the data onto standardized forms. Results We report on 186 patients with MIS-C in 26 states. The median age was 8.3 years, 115 patients (62%) were male, 135 (73%) had previously been healthy, 131 (70%) were positive for SARS-CoV-2 by RT-PCR or antibody testing, and 164 (88%) were hospitalized after April 16, 2020. Organ-system involvement included the gastrointestinal system in 171 patients (92%), cardiovascular in 149 (80%), hematologic in 142 (76%), mucocutaneous in 137 (74%), and respiratory in 131 (70%). The median duration of hospitalization was 7 days (interquartile range, 4 to 10); 148 patients (80%) received intensive care, 37 (20%) received mechanical ventilation, 90 (48%) received vasoactive support, and 4 (2%) died. Coronary-artery aneurysms (z scores ≥2.5) were documented in 15 patients (8%), and Kawasaki’s disease–like features were documented in 74 (40%). Most patients (171 [92%]) had elevations in at least four biomarkers indicating inflammation. The use of immunomodulating therapies was common: intravenous immune globulin was used in 144 (77%), glucocorticoids in 91 (49%), and interleukin-6 or 1RA inhibitors in 38 (20%). Conclusions Multisystem inflammatory syndrome in children associated with SARS-CoV-2 led to serious and life-threatening illness in previously healthy children and adolescents. (Funded by the Centers for Disease Control and Prevention.)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2

              In communities with high rates of coronavirus disease 2019, reports have emerged of children with an unusual syndrome of fever and inflammation.
                Bookmark

                Author and article information

                Contributors
                Dr.mbanakar@gmail.com
                Shiimaa83@gmail.com
                Journal
                Clin Exp Dent Res
                Clin Exp Dent Res
                10.1002/(ISSN)2057-4347
                CRE2
                Clinical and Experimental Dental Research
                John Wiley and Sons Inc. (Hoboken )
                2057-4347
                21 August 2023
                October 2023
                : 9
                : 5 ( doiID: 10.1002/cre2.v9.5 )
                : 922-934
                Affiliations
                [ 1 ] Department of Dentistry Islamic Azad University Tehran Iran
                [ 2 ] Department of Pediatric Dentistry, School of Dentistry Ahvaz Jundishapour University of Medical Sciences Ahvaz Iran
                [ 3 ] Department of Oral and Maxillofacial Surgery School of Dentistry, Alborz University of Medical Sciences Karaj Iran
                [ 4 ] Dental Research Center, Dentistry Research Institute Tehran University of Medical Sciences Tehran Iran
                [ 5 ] Department of Pediatric Dentistry, Faculty of Dentistry Shahed University Tehran Iran
                [ 6 ] Department of Periodontics and Oral Medicine University of Michigan School of Dentistry Ann Arbor Michigan USA
                [ 7 ] Centre for Interdisciplinary Research in Health (CIIS) Universidade Católica Portuguesa Viseu Portugal
                [ 8 ] Department of Prosthodontics, Faculty of Stomatology Yerevan State Medical University after Mkhitar Heratsi Armenia
                [ 9 ] Department of Pediatrics, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran
                [ 10 ] Department of Oral Medicine, Faculty of Dentistry Shahed University Tehran Iran
                Author notes
                [*] [* ] Correspondence Morteza Banakar, Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

                Email: Dr.mbanakar@ 123456gmail.com

                Shima Imannezhad, Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

                Email: Shiimaa83@ 123456gmail.com

                Author information
                http://orcid.org/0000-0003-1715-0198
                http://orcid.org/0000-0002-3634-7992
                https://orcid.org/0000-0003-3022-4390
                http://orcid.org/0000-0002-5537-2763
                Article
                CRE2776
                10.1002/cre2.776
                10582234
                37602892
                1048c110-039c-4287-a700-3bd44d6be47b
                © 2023 The Authors. Clinical and Experimental Dental Research published by John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 09 August 2023
                : 07 June 2023
                : 10 August 2023
                Page count
                Figures: 1, Tables: 2, Pages: 13, Words: 9193
                Funding
                Funded by: None
                Categories
                Review Article
                Review Article
                Custom metadata
                2.0
                October 2023
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.4 mode:remove_FC converted:17.10.2023

                child,covid‐19,oral health,oral manifestations,oral mucosal lesions,pediatric patients

                Comments

                Comment on this article